MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment
Yanping Gao(Nanjing General Hospital of Nanjing Military Command), Longbang Chen(Shanghai Jiao Tong University), Siqi Han(China Agricultural University), Bing Feng(Chinese Academy of Sciences), Rui Wang(Shanghai University of Traditional Chinese Medicine), Xiaoyuan Chu(Nanjing University of Chinese Medicine), Lu Lu(Fudan University), Yitian Chen(Southern Medical University)
Cited by 68
Related Papers
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
|The Lancet|2017|856
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
|Emerging Microbes & Infections|2021|474
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
|Nature Biotechnology|2024|258
Emerging SARS-CoV-2 variants expand species tropism to murines
|EBioMedicine|2021|192